Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis

Background. Tetrahydrocurcuminoids (THCs) are among the major metabolites of curcuminoids with a higher bioavailability and physiological stability and exhibit a broad spectrum of therapeutic activities. The objective of this study was to evaluate the efficacy of THCs in patients suffering from cank...

Full description

Bibliographic Details
Main Authors: Muhammed Majeed, Shaheen Majeed, Kalyanam Nagabhushanam
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2020/6611877
id doaj-07a51028dfb6480a8ae75f7f86f7aaab
record_format Article
spelling doaj-07a51028dfb6480a8ae75f7f86f7aaab2020-12-28T01:30:35ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-42882020-01-01202010.1155/2020/6611877Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and GingivitisMuhammed Majeed0Shaheen Majeed1Kalyanam Nagabhushanam2Sami-Sabinsa Group Ltd.Sabinsa CorporationSabinsa CorporationBackground. Tetrahydrocurcuminoids (THCs) are among the major metabolites of curcuminoids with a higher bioavailability and physiological stability and exhibit a broad spectrum of therapeutic activities. The objective of this study was to evaluate the efficacy of THCs in patients suffering from canker sore and gingivitis designed as an exploratory clinical trial. Methods. This is an open label prospective pilot clinical trial carried out at two clinical centers: Noble Hospital, Pune, Maharashtra, and Sri Venkateshwara Hospital, Bangalore, Karnataka in India. Participants were assigned to 21 days of treatment with chewable oral THCs supplement. Patients were instructed to self-administer one chewable tablet containing 100 mg of THCs twice daily for up to 21 days. This clinical trial was registered at a public Clinical Trial Registry in India (http://www.ctri.nic.in). Thirty-one canker sore and twenty-nine gingivitis patients participated in this study. Body mass index, throat numbness/relief, Visual Analog Scale (VAS) pain score, canker sore lesions, gingival appearance, inflammation and bleeding were assessed before and after treatment, at 14 and 21 days. Vital signs and laboratory parameters were assessed for safety. Results. THCs treatment significantly reduced the reddening at the site, difficulty in chewing, swallowing, and VAS pain score in the canker sore patients. Further, both single and multiple lesions were completely healed. In gingivitis patients, gingival appearance, bleeding, and inflammation were significantly reduced. No adverse effects were observed during the study. Conclusion. Overall, the findings of this study show that supplementation of THCs for 21 days reduced the pain and prevented the progression of the disease in patients suffering from canker sore and gingivitis without adverse side effects.http://dx.doi.org/10.1155/2020/6611877
collection DOAJ
language English
format Article
sources DOAJ
author Muhammed Majeed
Shaheen Majeed
Kalyanam Nagabhushanam
spellingShingle Muhammed Majeed
Shaheen Majeed
Kalyanam Nagabhushanam
Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
Evidence-Based Complementary and Alternative Medicine
author_facet Muhammed Majeed
Shaheen Majeed
Kalyanam Nagabhushanam
author_sort Muhammed Majeed
title Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
title_short Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
title_full Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
title_fullStr Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
title_full_unstemmed Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
title_sort efficacy and safety of tetrahydrocurcuminoids for the treatment of canker sore and gingivitis
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-4288
publishDate 2020-01-01
description Background. Tetrahydrocurcuminoids (THCs) are among the major metabolites of curcuminoids with a higher bioavailability and physiological stability and exhibit a broad spectrum of therapeutic activities. The objective of this study was to evaluate the efficacy of THCs in patients suffering from canker sore and gingivitis designed as an exploratory clinical trial. Methods. This is an open label prospective pilot clinical trial carried out at two clinical centers: Noble Hospital, Pune, Maharashtra, and Sri Venkateshwara Hospital, Bangalore, Karnataka in India. Participants were assigned to 21 days of treatment with chewable oral THCs supplement. Patients were instructed to self-administer one chewable tablet containing 100 mg of THCs twice daily for up to 21 days. This clinical trial was registered at a public Clinical Trial Registry in India (http://www.ctri.nic.in). Thirty-one canker sore and twenty-nine gingivitis patients participated in this study. Body mass index, throat numbness/relief, Visual Analog Scale (VAS) pain score, canker sore lesions, gingival appearance, inflammation and bleeding were assessed before and after treatment, at 14 and 21 days. Vital signs and laboratory parameters were assessed for safety. Results. THCs treatment significantly reduced the reddening at the site, difficulty in chewing, swallowing, and VAS pain score in the canker sore patients. Further, both single and multiple lesions were completely healed. In gingivitis patients, gingival appearance, bleeding, and inflammation were significantly reduced. No adverse effects were observed during the study. Conclusion. Overall, the findings of this study show that supplementation of THCs for 21 days reduced the pain and prevented the progression of the disease in patients suffering from canker sore and gingivitis without adverse side effects.
url http://dx.doi.org/10.1155/2020/6611877
work_keys_str_mv AT muhammedmajeed efficacyandsafetyoftetrahydrocurcuminoidsforthetreatmentofcankersoreandgingivitis
AT shaheenmajeed efficacyandsafetyoftetrahydrocurcuminoidsforthetreatmentofcankersoreandgingivitis
AT kalyanamnagabhushanam efficacyandsafetyoftetrahydrocurcuminoidsforthetreatmentofcankersoreandgingivitis
_version_ 1714981074199642112